Log in

H. Lundbeck A/S- News Headlines (OTCMKTS:HLUYY)

$34.86
+0.02 (+0.06 %)
(As of 11/15/2019 04:00 PM ET)
Today's Range
$34.83
Now: $34.86
$34.91
50-Day Range
$31.80
MA: $33.73
$36.45
52-Week Range
$31.35
Now: $34.86
$46.35
Volume1,263 shs
Average Volume3,462 shs
Market Capitalization$6.94 billion
P/E Ratio9.27
Dividend Yield3.64%
Beta0.04

Headlines

H. Lundbeck A/S- (OTCMKTS HLUYY) News Headlines

Source:
DateHeadline
FY2019 EPS Estimates for H. Lundbeck A/S- (OTCMKTS:HLUYY) Boosted by AnalystFY2019 EPS Estimates for H. Lundbeck A/S- (OTCMKTS:HLUYY) Boosted by Analyst
www.americanbankingnews.com - November 11 at 3:20 AM
Q4 2019 EPS Estimates for H. Lundbeck A/S- Decreased by Analyst (OTCMKTS:HLUYY)Q4 2019 EPS Estimates for H. Lundbeck A/S- Decreased by Analyst (OTCMKTS:HLUYY)
www.americanbankingnews.com - November 8 at 6:46 PM
Alpha Synuclein Market Competitive Analysis With Growth Forecast Till 2025Alpha Synuclein Market Competitive Analysis With Growth Forecast Till 2025
www.marketwatch.com - November 8 at 1:52 PM
H. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q3 2019 Results - Earnings Call TranscriptH. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 1:18 PM
H. Lundbeck A/S 2019 Q3 - Results - Earnings Call PresentationH. Lundbeck A/S 2019 Q3 - Results - Earnings Call Presentation
seekingalpha.com - November 5 at 1:06 PM
Danish drugmaker Lundbeck ups profit outlook on improved salesDanish drugmaker Lundbeck ups profit outlook on improved sales
www.reuters.com - November 5 at 8:05 AM
H. Lundbeck A/S reports 9M resultsH. Lundbeck A/S reports 9M results
seekingalpha.com - November 5 at 8:05 AM
UPDATE 1-Lundbeck hikes profit outlook, eyes return to growth in 2020UPDATE 1-Lundbeck hikes profit outlook, eyes return to growth in 2020
finance.yahoo.com - November 5 at 8:05 AM
Alzheimers Disease Treatments Market May Set New Growth Story | Eisai, Forest LaboratoriesAlzheimer's Disease Treatments Market May Set New Growth Story | Eisai, Forest Laboratories
www.marketwatch.com - November 4 at 2:02 PM
Alzheimers Therapeutics Market to Eyewitness Massive Growth by 2025Alzheimers Therapeutics Market to Eyewitness Massive Growth by 2025
www.marketwatch.com - November 2 at 2:00 PM
Alzheimers Drug Market Latest Innovations, Drivers and Forecast to 2030Alzheimers Drug Market Latest Innovations, Drivers and Forecast to 2030
www.marketwatch.com - October 31 at 8:54 AM
Antipsychotic Drugs Market to Reach US$ 20,539.5 Mn by 2026; Schizophrenia Segment to Witness Rapid GrowthAntipsychotic Drugs Market to Reach US$ 20,539.5 Mn by 2026; Schizophrenia Segment to Witness Rapid Growth
www.marketwatch.com - October 23 at 4:30 AM
Parkinsons Disease Drug Market Insights and Global Outlook During 2019-2025Parkinson's Disease Drug Market Insights and Global Outlook During 2019-2025
www.marketwatch.com - October 18 at 3:39 PM
The H. Lundbeck (CPH:LUN) Share Price Has Gained 97% And Shareholders Are Hoping For MoreThe H. Lundbeck (CPH:LUN) Share Price Has Gained 97% And Shareholders Are Hoping For More
finance.yahoo.com - October 9 at 12:34 PM
Antidepressants Market Future Lookout by Top Key Players H Lundbeck, Astrazeneca, Eli Lilly and Company, Sun PharmaceuticalsAntidepressants Market Future Lookout by Top Key Players H Lundbeck, Astrazeneca, Eli Lilly and Company, Sun Pharmaceuticals
www.marketwatch.com - October 4 at 4:05 PM
Antidepressants Market Report by Recent Trends, Major Driving Factors and Business Growth Strategies and Forecast 2024Antidepressants Market Report by Recent Trends, Major Driving Factors and Business Growth Strategies and Forecast 2024
www.marketwatch.com - October 1 at 7:38 AM
Global General Anxiety Disorder Market To Flourish And Reach USD 3,775 million By 2024Global General Anxiety Disorder Market To Flourish And Reach USD 3,775 million By 2024
www.marketwatch.com - September 30 at 4:12 PM
Alzheimers Drugs Market forecasting 2019 - 2030 by Trends, Growth, Share, Distribution Channel, Key Players & AnalysisAlzheimer's Drugs Market forecasting 2019 - 2030 by Trends, Growth, Share, Distribution Channel, Key Players & Analysis
www.marketwatch.com - September 23 at 11:50 PM
Lundbeck Makes A Large M&A Move, But The Target Will Be Somewhat ControversialLundbeck Makes A Large M&A Move, But The Target Will Be Somewhat Controversial
seekingalpha.com - September 18 at 5:30 AM
SHAREHOLDER ALERT: WeissLaw LLP Investigates Alder Biopharmaceuticals, Inc.SHAREHOLDER ALERT: WeissLaw LLP Investigates Alder Biopharmaceuticals, Inc.
finance.yahoo.com - September 18 at 5:30 AM
Does H. Lundbeck A/S's (CPH:LUN) P/E Ratio Signal A Buying Opportunity?Does H. Lundbeck A/S's (CPH:LUN) P/E Ratio Signal A Buying Opportunity?
finance.yahoo.com - September 9 at 8:21 AM
Memantine Industry 2019 Market Size, Segments, Key Regions, Future Scope, Growth Factors, Company Profiles and Forecast till 2026Memantine Industry 2019 Market Size, Segments, Key Regions, Future Scope, Growth Factors, Company Profiles and Forecast till 2026
www.marketwatch.com - September 7 at 10:27 AM
What are the key Player impacting the growth of the Hydroxytryptamine Receptor market?What are the key Player impacting the growth of the Hydroxytryptamine Receptor market?
www.marketwatch.com - August 27 at 5:08 PM
Lundbecks M&A Flexibility May Be Its Greatest Asset TodayLundbeck's M&A Flexibility May Be Its Greatest Asset Today
seekingalpha.com - August 20 at 5:24 PM
Alzheimer’s Drugs Market 2019-2030 | Prominent Players F.Hoffmann-La Roche Ltd, DAIICHI SANKYO COMPANY, AC Immune, Novartis AG, El.En. S.P.AAlzheimer’s Drugs Market 2019-2030 | Prominent Players F.Hoffmann-La Roche Ltd, DAIICHI SANKYO COMPANY, AC Immune, Novartis AG, El.En. S.P.A
www.marketwatch.com - August 20 at 9:02 AM
Is There An Opportunity With H. Lundbeck A/S's (CPH:LUN) 42% Undervaluation?Is There An Opportunity With H. Lundbeck A/S's (CPH:LUN) 42% Undervaluation?
finance.yahoo.com - August 20 at 9:02 AM
H. Lundbeck A/S 2019 Q2 - Results - Earnings Call SlidesH. Lundbeck A/S 2019 Q2 - Results - Earnings Call Slides
seekingalpha.com - August 14 at 10:10 AM
Is H. Lundbeck (HLUYY) a Profitable Pick for Value Investors?Is H. Lundbeck (HLUYY) a Profitable Pick for Value Investors?
finance.yahoo.com - August 14 at 10:10 AM
What Can We Expect From H. Lundbeck A/Ss (CPH:LUN) Earnings In Next 12 Months?What Can We Expect From H. Lundbeck A/S's (CPH:LUN) Earnings In Next 12 Months?
finance.yahoo.com - July 29 at 9:15 AM
What Can We Expect From H. Lundbeck A/S's (CPH:LUN) Earnings In Next 12 Months?What Can We Expect From H. Lundbeck A/S's (CPH:LUN) Earnings In Next 12 Months?
finance.yahoo.com - July 29 at 9:15 AM
Global Alzheimers Therapeutics Market 2019 exhibiting a CAGR of 8.20%Global Alzheimer's Therapeutics Market 2019 exhibiting a CAGR of 8.20%
www.marketwatch.com - July 10 at 10:33 AM
Do Directors Own H. Lundbeck A/S (CPH:LUN) Shares?Do Directors Own H. Lundbeck A/S (CPH:LUN) Shares?
finance.yahoo.com - July 9 at 10:39 AM
Is H. Lundbeck A/S (CPH:LUN) As Strong As Its Balance Sheet Indicates?Is H. Lundbeck A/S (CPH:LUN) As Strong As Its Balance Sheet Indicates?
finance.yahoo.com - June 19 at 10:22 AM
Cerecor Appoints Keith Schmidt to its Board of DirectorsCerecor Appoints Keith Schmidt to its Board of Directors
www.globenewswire.com - June 12 at 6:54 PM
Parkinsons Disease Drug Market Projected to Show Strong Growth | Merck, Akorn, GSK, Novartis, Boehringer IngelheimParkinson's Disease Drug Market Projected to Show Strong Growth | Merck, Akorn, GSK, Novartis, Boehringer Ingelheim
www.marketwatch.com - June 9 at 4:14 PM
Does H. Lundbeck A/S (CPH:LUN) Have A Place In Your Dividend Portfolio?Does H. Lundbeck A/S (CPH:LUN) Have A Place In Your Dividend Portfolio?
finance.yahoo.com - May 30 at 10:35 AM
Anti-Epileptic Drugs Market Key Manufactures and Opportunity Analysis By 2024Anti-Epileptic Drugs Market Key Manufactures and Opportunity Analysis By 2024
www.marketwatch.com - May 29 at 5:06 PM
What Do Analysts Think About H. Lundbeck A/Ss (CPH:LUN) Earnings Trend?What Do Analysts Think About H. Lundbeck A/S's (CPH:LUN) Earnings Trend?
finance.yahoo.com - May 10 at 10:38 AM
What Do Analysts Think About H. Lundbeck A/S's (CPH:LUN) Earnings Trend?What Do Analysts Think About H. Lundbeck A/S's (CPH:LUN) Earnings Trend?
finance.yahoo.com - May 10 at 10:38 AM
Lundbeck, Like The Dude, Will Try To AbideLundbeck, Like The Dude, Will Try To Abide
seekingalpha.com - May 9 at 5:10 PM
Heed Analysts Advice on Lundbeck: Sit TightHeed Analysts' Advice on Lundbeck: Sit Tight
finance.yahoo.com - May 9 at 10:33 AM
Lundbeck to Buy Abide Therapeutics for Up to $400 MillionLundbeck to Buy Abide Therapeutics for Up to $400 Million
www.wsj.com - May 7 at 10:31 AM
H. Lundbeck scoops up Abide for ~$400M, including milestone paymentH. Lundbeck scoops up Abide for ~$400M, including milestone payment
seekingalpha.com - May 6 at 5:12 PM
Lundbeck scoops up Abide for up to $400MLundbeck scoops up Abide for up to $400M
seekingalpha.com - May 6 at 5:12 PM
Lundbeck to acquire Abide Therapeutics, adding a unique discovery platform and a lead compound in an exploratory phase IIa program for Tourette’sLundbeck to acquire Abide Therapeutics, adding a unique discovery platform and a lead compound in an exploratory phase IIa program for Tourette’s
www.globenewswire.com - May 6 at 10:34 AM
Anti-Suicide Drugs Market 2019 Global Industry Sales, Supply, Consumption, Demand, Analysis and Forecasts to 2025Anti-Suicide Drugs Market 2019 Global Industry Sales, Supply, Consumption, Demand, Analysis and Forecasts to 2025
www.marketwatch.com - April 29 at 10:23 AM
Did You Miss H. Lundbeck's (CPH:LUN) 87% Share Price Gain?Did You Miss H. Lundbeck's (CPH:LUN) 87% Share Price Gain?
finance.yahoo.com - April 16 at 12:04 PM
Drugmakers pay $123 million to resolve U.S. charity kickback probeDrugmakers pay $123 million to resolve U.S. charity kickback probe
finance.yahoo.com - April 4 at 10:46 AM
Benzodiazepine Market Share Analysis, Strategies, Revenue and Forecasts to 2022Benzodiazepine Market Share Analysis, Strategies, Revenue and Forecasts to 2022
www.marketwatch.com - March 28 at 11:10 AM
Industry Consortium Launched to Qualify Biomarkers for Schizophrenia Drug DevelopmentIndustry Consortium Launched to Qualify Biomarkers for Schizophrenia Drug Development
finance.yahoo.com - March 20 at 10:09 AM
This page was last updated on 11/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel